Arnout Ploos van Amstel
Founder at Moonlake Immunotherapeutics AG
Network origin in Arnout Ploos van Amstel first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Khondrion BV
 Khondrion BV Pharmaceuticals: MajorHealth Technology Khondrion BV is a Dutch clinical-stage biopharmaceutical company that focuses on discovering and developing therapies for mitochondrial diseases. The company is based in Nijmegen, Netherlands, and was founded in 2012 by Jan Smeitink, who has been the CEO since then. The company's lead drug candidate, sonlicromanol, is a first-in-class, oral small molecule that targets key underlying mechanisms of primary mitochondrial disease. The compound has been granted orphan drug designations for the treatment of various mitochondrial diseases. Khondrion collaborates with a clinical and academic network and patient organizations internationally to accelerate the discovery and development of its potential medicines.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Arnout Ploos van Amstel via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| VERNALIS | Pharmaceuticals: Major | Chief Executive Officer | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Biotechnology | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Freiburg | College/University | Undergraduate Degree | |
| University of Oxford | College/University | Doctorate Degree | |
| University of Glasgow | College/University | Undergraduate Degree | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Wake Forest University | College/University | Undergraduate Degree | |
| University of Cambridge | College/University | Graduate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal | |
| Yale University | College/University | Graduate Degree Corporate Officer/Principal | |
| The University of Colorado | College/University | Corporate Officer/Principal | |
| University of Bristol | College/University | Undergraduate Degree | |
| University of Gottingen | College/University | Doctorate Degree | |
| University of Hannover | College/University | Undergraduate Degree | |
| University of Groningen | College/University | Doctorate Degree | |
| University of Turin | College/University | Doctorate Degree | |
| University of Minho | College/University | Corporate Officer/Principal | |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
BiVACOR, Inc.
 BiVACOR, Inc. Medical SpecialtiesHealth Technology BiVACOR, Inc. develops and manufactures medical device. The firm specializes in rotary blood pumps, biomedical engineering. The company was founded by Daniel Timms in 2008 and is headquartered in Houston, TX. | Medical Specialties | Director/Board Member | |
| Columbia Business School | College/University | Masters Business Admin | |
| IMMUNEERING CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Dermatologikum Hamburg GmbH
 Dermatologikum Hamburg GmbH Medical/Nursing ServicesHealth Services Dermatologikum Hamburg GmbH operates dermatologist clinics. Its services include prevention and skin checks, phototherapy, general dermatology, acne and rosacea, hair and scalp disorders, skin cancer and dermatological oncology, psoriasis, neurodermatitis and vascular & venous disease treatment. The company was founded by Volker Steinkraus in September 1997 and is headquartered in Hamburg, Germany. | Medical/Nursing Services | Corporate Officer/Principal | |
Expansion Therapeutics, Inc.
 Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Pharmaceuticals: Major | Director/Board Member | |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Founder | |
Cormorant Asset Management LLC/Private Equity/
 Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
derma2go AG
 derma2go AG Internet Software/ServicesTechnology Services Derma2go AG operates an online platform for dermatological consultation. The company is based in Zurich, Switzerland. The Swiss company was founded in 2018 by Christian Greis and Vahid Djamei. Christian Greis has been the CEO since 2018. | Internet Software/Services | Director/Board Member | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
ONK Therapeutics Ltd.
 ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Biotechnology | Director/Board Member | |
Kestrel Therapeutics, Inc.
 Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kestrel Therapeutics, Inc. operates as a biotechnology development company. The company is based in Wayland, MA. The CEO of the company is Frank G. Haluska. | Miscellaneous Commercial Services | Director/Board Member | |
| Cormorantasset Management LP | Corporate Officer/Principal | ||
| MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Founder Director of Finance/CFO Chief Tech/Sci/R&D Officer Director/Board Member | |
Blossom Biosciences Ltd.
 Blossom Biosciences Ltd. BiotechnologyHealth Technology Blossom Biosciences Ltd. provides molecular and cell biology research services. The company is based in Hong Kong, Hong Kong. Andrew J. Phillips has been the CEO of the Chinese company since 2021. | Biotechnology | Chief Executive Officer | |
| JeruCON Beratungsgesellschaft mbH | Founder | ||
| Aleksia Therapeutics, Inc. | Chief Executive Officer | ||
| Blossom Biomedicines USA, Inc. | Director/Board Member | ||
| Moonlake Immunotherapeutics Ltd. | Director/Board Member | ||
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Godfrey Huggins School of Medicine | College/University | Undergraduate Degree | |
Nexo Therapeutics, Inc.
 Nexo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexo Therapeutics is a small molecule oncology company that focuses on discovering and developing new drugs for cancer patients who do not have effective treatments. The company is based in Littleton, CO and Watertown, MA. The company uses covalent ligand discovery, chemical biology, cancer biology, and medicinal chemistry to target the underlying causes of cancer through innovative methods. Nexo Therapeutics was founded by John Athanosopoulos, Andrew J. Phillips, Michael Kim, and Rhamy Zeid. Andrew J. Phillips has been the CEO of the company since 2022. | Pharmaceuticals: Major | Founder | |
| Dermagnostix GmbH | Director/Board Member | ||
| Proderma Foundation | Director/Board Member |
Statistics
International
| United States | 26 |
| United Kingdom | 9 |
| Germany | 8 |
| Switzerland | 4 |
| Netherlands | 3 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 17 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 3 |
Operational
| Director/Board Member | 60 |
| Corporate Officer/Principal | 27 |
| Independent Dir/Board Member | 20 |
| Chief Executive Officer | 14 |
| Founder | 11 |
Most connected contacts
| Insiders | |
|---|---|
| Catherine Moukheibir | 29 |
| Andrew Phillips | 23 |
| Simon Sturge | 20 |
| Ramnik Xavier | 11 |
| Kristian Reich | 10 |
| Spike Loy | 9 |
| Matthias Bodenstedt | 7 |
| Charles de Water | 6 |
| Jorge da Silva | 6 |
| Oliver Daltrop | 5 |
| Kara Lassen | 5 |
| Jan Smeitink | 1 |
- Stock Market
- Insiders
- Arnout Ploos van Amstel
- Company connections
